Elliott Fegelman, MD, on J&J's Ethicon Announcement: "Project Game Changer"

Dr. Elliott Fegelman, therapeutic area lead for Metabolics at Johnson & Johnson Innovation, discusses "Project Game Changer" and what it means for the future of bariatric surgery.

Also presented at the 22nd World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders.

For more content on bariatric surgery, visit our Medical Resource Center

Submit Feedback